Cargando…
Potential mechanism of circRNA_000585 in cholangiocarcinoma
OBJECTIVE: Circular RNA (circRNA) plays a vital role in the development and progression of malignancies, however, the function of circRNAs in cholangiocarcinoma (CCA) remains unexplored. The aim of this study was to investigate circRNA expression in CCA versus para-cancer tissues, and elucidate any...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246500/ https://www.ncbi.nlm.nih.gov/pubmed/34182814 http://dx.doi.org/10.1177/03000605211024501 |
_version_ | 1783716326139756544 |
---|---|
author | Yi, Fengming Xin, Longxiang Feng, Long |
author_facet | Yi, Fengming Xin, Longxiang Feng, Long |
author_sort | Yi, Fengming |
collection | PubMed |
description | OBJECTIVE: Circular RNA (circRNA) plays a vital role in the development and progression of malignancies, however, the function of circRNAs in cholangiocarcinoma (CCA) remains unexplored. The aim of this study was to investigate circRNA expression in CCA versus para-cancer tissues, and elucidate any potential associated mechanisms. METHODS: Differential expression of circRNAs between CCA and para-cancer tissue was analysed by microarray hybridization, and validated by real-time quantitative reverse transcription–polymerase chain reaction (qRT–PCR). The downstream pathway was investigated using bioinformatics and qRT–PCR. RESULTS: Microarray hybridization revealed 10 circRNAs with > 3-fold increased expression versus para-cancer (circRNA_002172, circRNA_002144, circRNA_001588, circRNA_000166, circRNA_000585, circRNA_000167, circRNA_402608, circRNA_006853, circRNA_001589, circRNA_008882), and three circRNAs with > 3-fold decreased expression (circRNA_406083, circRNA_104940, circRNA_006349). CircRNA_000585 was shown by qRT-PCR to be upregulated in tumour versus paired para-cancer tissue from 15 patients with CCA. Bioinformatics analysis revealed a potential pathway comprising circRNA_000585/microRNA-615-5p/angiomotin (AMOT)/Yes associated protein 1 (YAP) in CCA. RT–PCR validation of crucial molecule expression showed downregulation of miR-615-5p, and upregulation of AMOT and YAP in CCA tumours. CONCLUSION: Multiple circRNAs are dysregulated in CCA. CircRNA_000585 is upregulated in CCA, and may function by a circRNA_000585/miR-615-5p/AMOT/YAP pathway, which may be a novel CCA pathway. |
format | Online Article Text |
id | pubmed-8246500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82465002021-07-13 Potential mechanism of circRNA_000585 in cholangiocarcinoma Yi, Fengming Xin, Longxiang Feng, Long J Int Med Res Pre-Clinical Research Report OBJECTIVE: Circular RNA (circRNA) plays a vital role in the development and progression of malignancies, however, the function of circRNAs in cholangiocarcinoma (CCA) remains unexplored. The aim of this study was to investigate circRNA expression in CCA versus para-cancer tissues, and elucidate any potential associated mechanisms. METHODS: Differential expression of circRNAs between CCA and para-cancer tissue was analysed by microarray hybridization, and validated by real-time quantitative reverse transcription–polymerase chain reaction (qRT–PCR). The downstream pathway was investigated using bioinformatics and qRT–PCR. RESULTS: Microarray hybridization revealed 10 circRNAs with > 3-fold increased expression versus para-cancer (circRNA_002172, circRNA_002144, circRNA_001588, circRNA_000166, circRNA_000585, circRNA_000167, circRNA_402608, circRNA_006853, circRNA_001589, circRNA_008882), and three circRNAs with > 3-fold decreased expression (circRNA_406083, circRNA_104940, circRNA_006349). CircRNA_000585 was shown by qRT-PCR to be upregulated in tumour versus paired para-cancer tissue from 15 patients with CCA. Bioinformatics analysis revealed a potential pathway comprising circRNA_000585/microRNA-615-5p/angiomotin (AMOT)/Yes associated protein 1 (YAP) in CCA. RT–PCR validation of crucial molecule expression showed downregulation of miR-615-5p, and upregulation of AMOT and YAP in CCA tumours. CONCLUSION: Multiple circRNAs are dysregulated in CCA. CircRNA_000585 is upregulated in CCA, and may function by a circRNA_000585/miR-615-5p/AMOT/YAP pathway, which may be a novel CCA pathway. SAGE Publications 2021-06-29 /pmc/articles/PMC8246500/ /pubmed/34182814 http://dx.doi.org/10.1177/03000605211024501 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Pre-Clinical Research Report Yi, Fengming Xin, Longxiang Feng, Long Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title | Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title_full | Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title_fullStr | Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title_full_unstemmed | Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title_short | Potential mechanism of circRNA_000585 in cholangiocarcinoma |
title_sort | potential mechanism of circrna_000585 in cholangiocarcinoma |
topic | Pre-Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246500/ https://www.ncbi.nlm.nih.gov/pubmed/34182814 http://dx.doi.org/10.1177/03000605211024501 |
work_keys_str_mv | AT yifengming potentialmechanismofcircrna000585incholangiocarcinoma AT xinlongxiang potentialmechanismofcircrna000585incholangiocarcinoma AT fenglong potentialmechanismofcircrna000585incholangiocarcinoma |